DK1663257T3 - Anvendelse af laksativer til behandling af colon irritabile - Google Patents

Anvendelse af laksativer til behandling af colon irritabile

Info

Publication number
DK1663257T3
DK1663257T3 DK04756926T DK04756926T DK1663257T3 DK 1663257 T3 DK1663257 T3 DK 1663257T3 DK 04756926 T DK04756926 T DK 04756926T DK 04756926 T DK04756926 T DK 04756926T DK 1663257 T3 DK1663257 T3 DK 1663257T3
Authority
DK
Denmark
Prior art keywords
laxatives
treat colon
patient
therapeutically effective
bowel syndrome
Prior art date
Application number
DK04756926T
Other languages
English (en)
Inventor
Russell W Pelham
Mark Vb Cleveland
Jack A Dipalma
Original Assignee
Braintree Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Braintree Lab filed Critical Braintree Lab
Application granted granted Critical
Publication of DK1663257T3 publication Critical patent/DK1663257T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
DK04756926T 2003-07-09 2004-07-09 Anvendelse af laksativer til behandling af colon irritabile DK1663257T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48579703P 2003-07-09 2003-07-09
PCT/US2004/022392 WO2005007170A1 (en) 2003-07-09 2004-07-09 Method for treating irritable bowel syndrome using laxatives

Publications (1)

Publication Number Publication Date
DK1663257T3 true DK1663257T3 (da) 2009-04-14

Family

ID=34079160

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04756926T DK1663257T3 (da) 2003-07-09 2004-07-09 Anvendelse af laksativer til behandling af colon irritabile

Country Status (14)

Country Link
US (1) US20050152989A1 (da)
EP (1) EP1663257B1 (da)
JP (1) JP2007525476A (da)
AT (1) ATE419857T1 (da)
AU (1) AU2004257742A1 (da)
CA (1) CA2531445C (da)
CY (1) CY1108921T1 (da)
DE (1) DE602004018944D1 (da)
DK (1) DK1663257T3 (da)
ES (1) ES2319655T3 (da)
PL (1) PL1663257T3 (da)
PT (1) PT1663257E (da)
SI (1) SI1663257T1 (da)
WO (1) WO2005007170A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2546019A1 (en) * 2003-11-17 2005-06-02 Braintree Laboratories, Inc. Therapeutic peg solution concentrate
US7256202B2 (en) * 2003-12-31 2007-08-14 Halow George M Composition and method for treatment of hepatic encephalopathy
JP5259392B2 (ja) * 2005-05-31 2013-08-07 ウォーソー・オーソペディック・インコーポレーテッド 疼痛を治療するための組成物および方法
US20070082061A1 (en) * 2005-10-07 2007-04-12 Nelson Ayala Reduction of saltiness with sweeteners
US7985429B2 (en) 2006-03-03 2011-07-26 C. B. Fleet Company, Inc. Flavored colonic cleansing system
DE102006017672B4 (de) * 2006-04-12 2008-07-03 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung zur Verwendung als Laxativum
US20080118441A1 (en) * 2006-11-19 2008-05-22 Washington Joseph A Compositions and methods for the treatment of gastrointestinal conditions
US20090110758A1 (en) * 2007-10-25 2009-04-30 Seed John C Compositions and methods for promoting weight loss
US20090148413A1 (en) * 2007-12-11 2009-06-11 George Halow Method for treatment of irritable bowel syndrome
WO2010071225A1 (ja) * 2008-12-17 2010-06-24 キリンホールディングス株式会社 穀類植物種子由来の不溶性食物繊維を含有する過敏性腸症候群抑制用物質
US20100178360A1 (en) * 2009-01-13 2010-07-15 Universite Libre De Bruxelles Nutritive composition
GB0913295D0 (en) 2009-07-30 2009-09-02 Norgine Bv Improvements in and relating to pharmaceutical compositions
FR2963738B1 (fr) * 2010-08-10 2012-09-28 Assist Publ Hopitaux De Paris Compose destine au traitement des douleurs abdominales fonctionnelles
US8630141B2 (en) 2011-01-28 2014-01-14 Micron Technology, Inc. Circuits and methods for providing refresh addresses and alternate refresh addresses to be refreshed
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
KR102257207B1 (ko) 2012-09-11 2021-05-31 노어긴 비.브이. Peg 및 아스코르베이트를 포함하는 조성물
RS59667B1 (sr) 2013-03-15 2020-01-31 Braintree Laboratories Inc Oralna farmaceutska kompozicija sulfatnih soli u obliku tableta dvostruke primene i postupci njihove upotrebe
JP2017514521A (ja) 2014-04-29 2017-06-08 コロナリーコンセプツ エルエルシー 電解質補給物をもたらすための食品、システム、方法、及びキット
KR102091852B1 (ko) 2015-03-02 2020-03-23 코로나리콘셉츠 엘엘씨 Peg 대사산물 및 peg 분해 생성물 검정을 위한 화합물 및 방법
WO2016175042A1 (ja) * 2015-04-30 2016-11-03 協和化学工業株式会社 マグネシウム化合物を有効成分として含有する医薬製剤
US20210196296A1 (en) * 2017-01-30 2021-07-01 Vibrant Ltd. Method for treating conditions of the gi tract using a vibrating ingestible capsule

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978529A (en) * 1988-05-25 1990-12-18 Denick Jr John Easily dispersible psyllium compositions
JP2609022B2 (ja) * 1990-11-29 1997-05-14 北陸製薬株式会社 ポリカルボフィルカルシウム含有製剤
US5710183A (en) * 1995-07-14 1998-01-20 Halow; George M. Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent
US5651988A (en) * 1995-08-18 1997-07-29 Xyrofin Oy Combination osmotic and bulk forming laxatives
AUPO763197A0 (en) * 1997-06-30 1997-07-24 Sigma Pharmaceuticals Pty Ltd Health supplement
US6048901A (en) * 1999-04-20 2000-04-11 Braintree Laboratories, Inc. Method of reducing intestinal gas, cramping and anorectal irritation
US7014862B2 (en) * 2002-05-20 2006-03-21 The Procter & Gamble Company Chewable compositions containing a gel-forming extract of psyllium

Also Published As

Publication number Publication date
ES2319655T3 (es) 2009-05-11
PT1663257E (pt) 2009-03-27
AU2004257742A1 (en) 2005-01-27
PL1663257T3 (pl) 2009-08-31
EP1663257A1 (en) 2006-06-07
SI1663257T1 (sl) 2009-06-30
DE602004018944D1 (de) 2009-02-26
EP1663257B1 (en) 2009-01-07
ATE419857T1 (de) 2009-01-15
WO2005007170A1 (en) 2005-01-27
CA2531445C (en) 2011-07-05
US20050152989A1 (en) 2005-07-14
JP2007525476A (ja) 2007-09-06
CA2531445A1 (en) 2005-01-27
CY1108921T1 (el) 2014-07-02

Similar Documents

Publication Publication Date Title
DK1663257T3 (da) Anvendelse af laksativer til behandling af colon irritabile
NO20050807L (no) Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
TW200631578A (en) Methods and compositions using immunomodulatory compounds for treatment and management of central nervous system injury
SG161259A1 (en) Method for treatment of constipation-predominant irritable bowel syndrome
CY1108217T1 (el) Μεθοδος χορηγησης βουπρενορφινης για τη θεραπεια της καταθλιψης
WO2004093831A3 (en) Cytokine-expressing cellular vaccine combinations
BR0308928A (pt) Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
WO2007130882A3 (en) Method for treatment of diarrhea-predominant irritable bowel syndrome
MXPA05010819A (es) Uso de antagonistas de opioide perifericos, especialmente metilnaltrexona para tratar sindrome de intestino irritable.
MX2007006066A (es) Inhibidores de jnk para el tratamiento de lesiones del snc.
EA200800755A1 (ru) Ikk ингибиторы, предназначенные для лечения эндометриоза
AR074313A1 (es) Metodo para tratar o prevenir la trombosis utilizando etexilato de dabigatran o una sal del mismo. uso. kit
TW200616639A (en) Methods for treating a mammal before, during and after cardiac arrest
DK0946157T3 (da) Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte
NO20073104L (no) Anvendelse av en 5-HT6 agonist for behandling og forebygging av neurodegenerative forstyrrelser
DK1255569T3 (da) Pax2 til behandling af nyresygdomme
ATE442188T1 (de) Bestrahlungseinrichtung
DK1383516T3 (da) Indgivelse af et polysaccharid samtidig med et kemoterapeutisk middel til behandling af cancer
DK1124566T3 (da) Ikke-fermenteret osmotisk laxativ til behandling og forebyggelse af colorectale cancere
PT1051187E (pt) Tratamento de linfomas foliculares usando inibidores da via da linfotoxina (lt)
NO984760L (no) Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
EA200101240A1 (ru) Использование мелатонина в медицине
EA200901062A1 (ru) Использование ингибиторов растворимой эпоксидгидролазы для предотвращения и лечения метаболического синдрома и соответствующих расстройств
NO20042758L (no) Fremgangsmate for behandling av en pasient som krever analgesi.
DK1073436T3 (da) Forbedret fremgangsmåde til udryddelse af helicobacter pylori